益心舒胶囊对心衰合并焦虑患者左心室功能和心率变异性的影响

摘要/Abstract

摘要： 目的探究分析益心舒胶囊对心力衰竭合并焦虑患者左心室功能和心率变异性的影响。方法选取2018年8月—2022年1月宁夏回族自治区人民医院收治的心力衰竭合并焦虑患者88例作为研究对象,根据随机数表法把88例患者分为中医组与传统组,每组44例。传统组予以常规治疗药物,中医组在其基础上加用益心舒胶囊治疗,所纳入患者治疗观察时长均为8周,测定与记录患者的左心室功能、心率变异性、焦虑情绪变化情况,同时随访患者的主要心血管不良事件发生情况。结果治疗8周后,两组焦虑自评量表（SAS）评分明显低于治疗前,中医组SAS评分也明显低于传统组,差异有统计学意义（P<0.05）。治疗8周后,两组左室射血分数明显高于治疗前,左心室舒张末期内径明显低于治疗前,中医组左室射血分数明显高于传统组,左心室舒张末期内径明显低于传统组,差异有统计学意义（P<0.05）。治疗8周后,两组相邻NN之差大于50 ms的个数占整个窦性心搏个数的比值（PNN50）、RR间期的平均值标准差（SDANN）均高于治疗前,中医组PNN50、SDANN与传统组相比也显著提高,差异有统计学意义（P<0.05）。所有患者随访1年,中医组的再发心力衰竭、心肌梗死、靶血管血运重建、心源性死亡等主要心血管不良事件发生率明显低于传统组,差异有统计学意义（P<0.05）。结论益心舒胶囊在心力衰竭合并焦虑患者的应用能改善患者的左心室功能,缓解患者的焦虑症状,也可改善患者的心率变异性状况,降低患者的随访主要心血管不良事件发生率。

关键词: 益心舒胶囊, 心力衰竭, 焦虑, 左心室, 心率变异性, 主要心血管不良事件

Abstract: Objective To investigate and analysis the effects of Yixinshu capsules on left ventricular function and heart rate variability in patients with heart failure combined with anxiety. Methods 88 patients with heart failure combined with anxiety admitted to People's Hospital of Ningxia from August 2018 to January 2022 were selected as the research subjects. Accorded to the randomized numerical table method, the patients were divided into the traditional Chinese medicine group of 44 cases and the traditional Chinese medicine group of 44 cases. The traditional group were treated with conventional treatment drugs, while the traditional Chinese medicine group were treated with Yixinshu capsules on top of it, and the duration of treatment and observation for all included patients was 8 weeks. Measured and recorded the left ventricular function, heart rate variability, and changes in anxiety of patients, and follow up on the occurrence of major cardiovascular adverse events. Results The anxiety SAS scores of the Chinese medicine group and the traditional group after 8 weeks of treatment were significantly lower than those before treatment (P<0.05), and the anxiety SAS scores of the Chinese medicine group after 8 weeks of treatment were also significantly lower than those of the traditional group (P<0.05). After 8 weeks of treatment, the left ventricular ejection fraction of the traditional Chinese medicine group were significantly higher than that before treatment (P<0.05), and the left ventricular end diastolic diameter were significantly lower than that before treatment (P<0.05). There were also significant difference compared between the traditional Chinese medicine group and the traditional group (P<0.05). After 8 weeks of treatment, the PNN50 and SDANN of the traditional Chinese medicine group and the traditional group were both higher than before treatment (P<0.05). After 8 weeks of treatment, the PNN50 and SDANN of the traditional Chinese medicine group were also significantly increased compared to the traditional group (P<0.05). All patients were followed up for 1 year. The incidence of major cardiovascular adverse events such as recurrent heart failure, myocardial infarction, target vessel revascularization, and cardiac death in the traditional Chinese medicine group were significantly lower than that in the traditional Chinese medicine group (P<0.05). Conclusion Yixinshu capsule can improve left ventricular function, alleviate anxiety symptoms, and improve heart rate variability in patients with heart failure and anxiety, reducing the incidence of major cardiovascular adverse events during follow-up.

Key words: yixinshu capsule, heart failure, anxiety, left ventricle, heart rate variability, major cardiovascular adverse events

中图分类号:

R973

木峰, 郝文娜. 益心舒胶囊对心衰合并焦虑患者左心室功能和心率变异性的影响[J]. 中华养生保健, 2024, 42(1): 15-19.

MU Feng, HAO Wen-na. The Effect of Yixinshu Capsule on Left Ventricular Function and Heart Rate Variability in Patients with Heart Failure Complicated with Anxiety[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(1): 15-19.

参考文献

[1] 刘永民,焦学昌,周国锋,等.益心舒胶囊联合替格瑞洛治疗急性心肌梗死的临床研究[J].现代药物与临床,2022,37(2):305-309.
[2] 傅梦薇,李洪峥,滕羽鸥,等.联用益心舒胶囊干预室性期前收缩有效性与安全性的Meta分析[J].中西医结合心脑血管病杂志,2022,20(2):197-206.
[3] MAHARJAN A, PENG M, RUSSELL B, et al.Investigation of the Optimal Parameters of Median Nerve Stimulation Using a Variety of Stimulation Methods and Its Effects on Heart Rate Variability: A Systematic Review[J]. Neuromodulation,2022,25(8):1268-1279.
[4] 施家希,沈淇,卿立金,等.3种常用益气养阴活血中成药治疗冠心病心绞痛的Meta分析[J].中西医结合心脑血管病杂志,2022,20(19):3587-3597.
[5] 李曼,金爱莲.阿替洛尔联合益心舒胶囊治疗稳定型心绞痛的临床观察[J].医药论坛杂志,2021,42(22):29-32.
[6] 陈静园,杨竞霄,吴赪.美托洛尔与益心舒胶囊联用对急诊冠心病心力衰竭患者心功能及用药安全性的影响[J].河北医药,2021,43(17):2633-2635,2639.
[7] 庞建中,杨继,陈善夫,等.通脉养心丸治疗气阴两虚型稳定型心绞痛疗效观察[J].现代中西医结合杂志,2021,30(23):2513-2517,2544.
[8] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[9] 于清华,刘淑荣,陈松柏,等.心衰中医辨证存在的问题与对策[J].世界科学技术-中医药现代化,2020,22(8):2936-2941.
[10] 段泉泉,胜利.焦虑及抑郁自评量表的临床效度[J].中国心理卫生杂志,2012,26(9):676-679.
[11] 何丽雅.心内科左心衰竭患者焦虑障碍的临床研究[J].中西医结合心血管病电子杂志,2019,7(4):76,79.
[12] 刘艳强. 益心舒胶囊联合地高辛治疗慢性肺源性心脏病的临床疗效研究[J].中国药物与临床,2020,20(21):3595-3597.
[13] 王晨,李仁东,刘学兵,等.益心舒胶囊治疗病毒性心肌炎气阴两虚证的抗氧化、抗炎作用观察[J].中国实验方剂学杂志,2020,26(14):129-134.
[14] 项昌培,周瑞,张晶晶,等.益心舒胶囊对心力衰竭大鼠心肌细胞钙调控蛋白的影响[J].中国中药杂志,2020,45(20):4984-4990.
[15] 张娜,史菲,霍明艳,等.益心舒胶囊联合西药治疗冠心病稳定型心绞痛疗效及对红细胞分布宽度、总胆红素、平均血小板体积、尿酸水平的影响[J].现代中西医结合杂志,2020,29(8):885-887.
[16] 赖诚民,邓建平.益心舒胶囊联合地高辛治疗慢性肺源性心脏病的临床研究[J].现代药物与临床,2019,34(6):1668-1672.
[17] 贾嵘,刘磊,云云.益心舒胶囊对COPD合并慢性右心功能不全病人血管内皮功能与凝血状态的影响[J].中西医结合心脑血管病杂志,2019,17(22):3544-3546.
[18] 唐仕欢,张晶晶,杨洪军.以中医理论指导的中药大品种临床定位案例研究——以益心舒胶囊为例[J].中国实验方剂学杂志,2019,25(15):197-201.
[19] 郭新响,张勇,方玲,等.益心舒胶囊联合尼可地尔对老年冠心病PCI术后病人心功能、血液流变学及血清ET-1、slox-1、hs-CRP水平的影响[J].中西医结合心脑血管病杂志,2019,17(22):3461-3464.
[20] 沈妍丽,张晖.螺内酯联合益心舒胶囊对左心室射血分数保留的心力衰竭肺动脉高压患者血管内皮功能、心肺功能和运动耐量的影响[J].现代中西医结合杂志,2019,28(29):3255-3259.
[21] 刘婧,王南丁,陶涛.益心舒胶囊对不稳定型心绞痛患者的症状改善作用及其对血清核因子κB、基质金属蛋白酶1水平的影响[J].实用心脑肺血管病杂志,2019,27(5):72-76.
[22] 王前,高建步.益心舒胶囊治疗2型糖尿病合并冠心病心绞痛的临床疗效分析[J].世界中医药,2017,12(5):1090-1093.
[23] 史胜楠,邓艳萍,刘建勋,等.中成药联合β受体阻滞剂治疗冠心病室性早搏网状Meta分析[J].中国中医药信息杂志,2022,29(5):30-37.